Publications by authors named "Ivan Arcari"

Claim this Profile
K
Key Predictors of Relevant Weight Loss in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease.
Nicola Pugliese, Ivan Arcari, Federica Cerini, Rosa Lombardi, Federica Turati

United European Gastroenterol J· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of artificial intelligence in staging and assessing of treatment response in MASH patients.
Reha Akpinar, Davide Panzeri, Camilla De Carlo, Vincenzo Belsito, Barbara Durante, Ivan Arcari

Front Med (Lausanne)· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Letter: Prioritising osteosarcopenia assessment in the ongoing care of patients with cholestatic liver diseases.
Ivan Arcari, Francesca Colapietro, Nicola Pugliese

Aliment Pharmacol Ther· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatitis C Virus Infection in the Elderly in the Era of Direct-Acting Antivirals: Evidence from Clinical Trials and Real Life.
Nicola Pugliese, Davide Polverini, Ivan Arcari, Stella De Nicola, Francesca Colapietro

Trop Med Infect Dis· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical features and management issues of NAFLD-related HCC: what we know so far.
Nicola Pugliese, Ludovico Alfarone, Ivan Arcari, Silvia Giugliano, Tommaso Lorenzo Parigi

Expert Rev Gastroenterol Hepatol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Osteosarcopenia in autoimmune cholestatic liver diseases: Causes, management, and challenges.
Nicola Pugliese, Ivan Arcari, Alessio Aghemo, Andrea G Lania, Ana Lleo

World J Gastroenterol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Eosinophils as Major Player in Type 2 Inflammation: Autoimmunity and Beyond.
Marco Folci, Giacomo Ramponi, Ivan Arcari, Aurora Zumbo, Enrico Brunetta

Adv Exp Med Biol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis